CD274 and breast carcinoma: revealed the differentiation trajectory of various immune cells in response to immunotherapy and the possible mechanism of activation.[18] They also found that the main cell types expressing PD‐L1 in breast cancer were not tumor cells but macrophages and dendritic cells, and the expression of PD‐L1 in the latter two cell types could predict the immunotherapy response.[18] Zhang et al.